Scott Kellen insider trades

Open-market stock purchases and sales by Scott Kellen, CFO & Secretary at DiaMedica Therapeutics Inc, from SEC Form 4 filings since Mar 7, 2011.

Track record: 100% of 6 scored buys are up 5% or more since purchase, averaging +102%.

Recent trades

DateStockTradeValue
Jun 1, 2026DMAC DiaMedica Therapeutics IncBought (not open market)—

Companies traded

  • DMAC DiaMedica Therapeutics Inc: 6 buys, last Jun 1, 2026
  • SNBP Sun BioPharma, Inc: 3 buys, last Feb 27, 2018
  • KIPS Kips Bay Medical, Inc: 3 buys, last Mar 10, 2015

Get free alerts when Scott Kellen files a new trade →